Konstantinopoulos, P. A., Zhou, N., Penson, R. T., Campos, S. M., Krasner, C. N., Wright, A. A., Porter, R. L., Horowitz, N. S., Bouberhan, S., Sawyer, H., Koppermann, L., Hayes, M., Polak, M., Shea, M., Widick, P., Cheng, S., Castro, C. M., Matulonis, U. A., Lee, E. K. (2025). Phase 2 study of letrozole, abemaciclib, and metformin in estrogen receptor (ER)–positive recurrent endometrial cancer (EC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.5513